Thursday October 4, 7:35 am Eastern Time
Press Release
SOURCE: 3-Dimensional Pharmaceuticals, Inc.
3-Dimensional Pharmaceuticals Announces Presentation at UBS Warburg
Conference
EXTON, Pa., Oct. 4 /PRNewswire/ -- 3-Dimensional Pharmaceuticals, Inc. (Nasdaq: DDDP - news) today announced that
John Gill, Executive Vice President and Chief Financial Officer, will present at the UBS Warburg Global Life Sciences
Conference on Monday, October 8, 2001 at 1:00 p.m. ET, at the Pierre Hotel in New York City.
3DP's presentation will be accessible to the public through conference call facilities listed below.
Live (domestic): 1-800-500-0177
Live (international): 1-719-457-2679
Recorded (domestic): 1-800-759-8603
Recorded (international): 1-402-220-8537
The recorded line will be available for up to four weeks after the conference.
About the Company
3DP (http://www.3dp.com) is an integrated bio-pharmaceuticals company dedicated to revolutionizing small molecule drug
discovery and development. 3DP's proprietary platform, DiscoverWorks®, can be applied to virtually any potential drug
target. It produces drug candidates suitable for development faster, with fewer resources and a higher probability of success
than using conventional drug discovery methods. 3DP is developing its own drug pipeline and collaborates with other
pharmaceutical companies in discovery and development.
SOURCE: 3-Dimensional Pharmaceuticals, Inc. |
